Review
Open access
Oct 2026
Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta-Analysis.
BACKGROUND Cisplatin- and carboplatin-based regimens are widely used in the treatment of head and neck squamous cell carcinoma (HNSCC), yet comparative evidence on survival and toxicity outcomes remains limited. While cisplatin is standard in many settings, carboplatin is often preferred in patients with comorbidities...
Samiya Rahim, Muskan Kumari, Eisha Abid et al.
· Head and Neck · 0 citations